The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer
Condition(s):Oligometastatic Gastrointestinal CancerLast Updated:November 12, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Oligometastatic Gastrointestinal CancerLast Updated:November 12, 2020Unknown status
Condition(s):Metastatic Non-small Cell Lung Cancer (NSCLC)Last Updated:October 20, 2021Completed
Condition(s):Colorectal CancerLast Updated:May 11, 2021Unknown status
Condition(s):Renal TumorLast Updated:May 9, 2023Recruiting
Condition(s):Hepatocellular Carcinoma(HCC)Last Updated:August 30, 2021Unknown status
Condition(s):Breast Cancer Stage IV; Oligometastatic DiseaseLast Updated:October 21, 2022Recruiting
Condition(s):Non Small Cell Lung Cancer; Interstitial Lung DiseaseLast Updated:February 29, 2024Active, not recruiting
Condition(s):OligometastasesLast Updated:March 1, 2024Completed
Condition(s):Prostate CancerLast Updated:November 24, 2020Unknown status
Condition(s):Metastatic TumorsLast Updated:December 13, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.